Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
International Journal of Oncology|May 16, 2002
Current status and future potential role of exemestane in the treatment of early and advanced breast cancer (Review)Enrico Crucitta, Monica N Fornier, Nathalia Locopo, et al.International Journal of Radiation Oncology, Biology, Physics|March 6, 2007
Long-term clinical outcomes of whole-breast irradiation delivered in the prone positionLauren D Stegman, Katherine P Beal, Margie A Hunt, et al.International Journal of Radiation Oncology, Biology, Physics|November 3, 2009
Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane eraShari Damast, Alice Y Ho, Leslie Montgomery, et al.Journal of Bone Oncology|June 20, 2017
Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone scoreVeronica Mariotti, David B Page, Oksana Davydov, et al.Breast Cancer Research and Treatment|July 15, 2021
Does preoperative MRI accurately stratify early-stage HER2 + breast cancer patients to upfront surgery vs neoadjuvant chemotherapy?Astrid Botty van den Bruele, Emanuela Ferraro, Varadan Sevilimedu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancerMonica N Fornier, Andrew D Seidman, Diana Lake, et al.The Breast Journal|May 22, 2012
Limited overall survival in patients with brain metastases from triple negative breast cancerPatrick G Morris, Conleth G Murphy, Divya Mallam, et al.Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|February 15, 2012
Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastasesPatrick G Morris, Maurizio Fazio, Azeez Farooki, et al.Cancer Prevention Research (Philadelphia, Pa.)|March 28, 2013
Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancerPatrick G Morris, Xi Kathy Zhou, Ginger L Milne, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 3, 2013
NCCN Task Force Report: Bone Health In Cancer CareJulie R Gralow, J Sybil Biermann, Azeez Farooki, et al.Pageof 3